BioMed Central | Articles which cite: Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer. Pulukuri SM, Estes N, Patel J, Rao JS Cancer Res 2007 Feb 1, 67:930-9 [PubMed Central] [PubMed] [Related articles]
2.	Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator. Pulukuri SM, Gorantla B, Rao JS J Biol Chem 2007 Dec 7, 282:35594-603 [PubMed Central] [PubMed] [Related articles]
3.	Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis. Dean JP, Nelson PS Br J Cancer 2008 Jan 29, 98:245-9 [PubMed Central] [PubMed] [Related articles]
4.	Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Kumar S, Weaver VM Cancer Metastasis Rev 2009 Jun, 28:113-27 [PubMed Central] [PubMed] [Related articles]
5.	Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling. McCabe NP, De S, Vasanji A, Brainard J, Byzova TV Oncogene 2007 Sep 13, 26:6238-43 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 4 articles in BioMed Central

printer friendly

to [Help]